Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis

First evidence of ruxolitinib efficacy for subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis. Supporting rationale for ruxolitinib use, not more aggressive treatment, in this context, questioning this condition’s neoplastic nature.

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Lévy, Romain, Fusaro, Mathieu, Guerin, Frédéric, Chetouani, Ahmed, Moshous, Despina, Fischer, Alain, de Saint Basile, Geneviève, Sepulveda, Fernando E., Neven, Bénédicte
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Exceptional Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160282/
https://ncbi.nlm.nih.gov/pubmed/32271897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados